Mohamed, Rania M.
Panthi, Bikash
Adrada, Beatriz E.
Boge, Medine
Candelaria, Rosalind P.
Chen, Huiqin
Guirguis, Mary S.
Hunt, Kelly K.
Huo, Lei
Hwang, Ken-Pin
Korkut, Anil
Litton, Jennifer K.
Moseley, Tanya W.
Pashapoor, Sanaz
Patel, Miral M.
Reed, Brandy
Scoggins, Marion E.
Son, Jong Bum
Thompson, Alastair
Tripathy, Debu
Valero, Vicente
Wei, Peng
White, Jason
Whitman, Gary J.
Xu, Zhan
Yang, Wei
Yam, Clinton
Ma, Jingfei
Rauch, Gaiane M.
Article History
Received: 26 July 2023
Accepted: 28 June 2024
First Online: 12 July 2024
Competing interests
: We would like to make the following disclosures: K.K.H. serves on the medical advisory boards for ArmadaHealth and AstraZeneca and receives research funding from Cairn Surgical, Eli Lilly and Company, and Lumicell. K.H is currently receiving research funding from Siemens Healthineers and has received research funding from GE. J.K.L. received grant or research support from Novartis, Medivation/Pfizer, Genentech, GSK, EMD-Serono, AstraZeneca, Medimmune, Zenith, and Merck; participated in the Speaker’s Bureau for MedLearning, Physicians’ Education Resource, Prime Oncology, Medscape, Clinical Care Options, and Medpage and receives royalty from UpToDate. The spouse of A.T works for Eli Lilly and Company. D.T. declares research contracts with Pfizer, Novartis, and Ployphor and is a consultant of AstraZeneca, GlaxoSmithKline, OncoPep, Gilead, Novartis, Pfizer, Personalis, and Sermonix. W.Y. receives royalties from Elsevier. J.M. is a consultant of C4 Imaging. G.M.R. receives research funding from GE Healthcare. No conflicts of interest were declared for the remaining authors. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.